FDA Approves Long-Lasting HIV Prevention Injection
The FDA has approved lenacapavir, a long-acting injectable HIV prevention drug that is nearly 100% effective with just two doses per year, representing a significant advancement in HIV prevention, though its high cost may limit access in low-income regions.